December 12, 2025

Amgen Scores Uplizna Expansion Into Generalized Myasthenia Gravis – BioSpace

December 12, 2025

FDA Approves Uplizna for Twice-Yearly Treatment of Antibody-Positive Generalized Myasthenia Gravis – geneonline.com

December 12, 2025

Here’s How AMGN Benefits From FDA Nod to Uplizna in Myasthenia Gravis – Zacks Investment Research

December 11, 2025

Getting a generalized MG diagnosis can take more than 2 years: Study – Myasthenia Gravis News

December 11, 2025

FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS – PR Newswire